Skip to content

reSET-O™ 1.1

by Pear Therapeutics, Inc. 2 variants

reSET-O 1.1, a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Cognitive Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., was cleared under FDA 510(k) K173681 on 10 Dec 2018 and listed in FDA GUDID on 26 Dec 2018 (UDI-DI 10851580008057); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026. FDA recalls on record: 2.

Active United States. Also listed in GUDID (US), not in commercial distribution.

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

510(k) K173681

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10851580008057 UDI-DI Date26 Dec 2018ListedStatusListed GUDID: not in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK173681 Date10 Dec 2018DecidedStatusActive

Official records

From the FDA record

Device description
reSET-O Mobile Application runs on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application. Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K173681 decided 10 Dec 2018 Active
  • FDA GUDID UDI-DI 10851580008057 listed 26 Dec 2018 Listed

Recalls

2 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-1925-2021 FDA Class II initiated 7 Jun 2021
    • Terminated Z-1926-2021 FDA Class II initiated 7 Jun 2021

    Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positive UDS results should not have resulted in access to a wheel spin.

Timeline

4 dated events

  1. Cleared FDA 510(k) K173681
  2. Listed FDA GUDID 10851580008057
  3. Recall initiated FDA recalls Z-1925-2021
  4. Recall initiated FDA recalls Z-1926-2021

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
reSET-O™
Generic name
Mental health/function therapeutic software, screen-viewed
Model / Ref / Catalog
1.1
Primary DI / UDI-DI
10851580008057
510(k) Number
FDA product code
PWE
GMDN term
Mental health/function therapeutic software, screen-viewed
Device class
Class II
Regulation number
882.5801
GUDID distribution status
Not in Commercial Distribution

Other devices from Pear Therapeutics, Inc.

See all devices from Pear Therapeutics, Inc. →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)